Literature DB >> 28444321

Evidence of Altered Brain Responses to Nicotine in an Animal Model of Attention Deficit/Hyperactivity Disorder.

Guillaume L Poirier1, Wei Huang1, Kelly Tam1, Joseph R DiFranza2,3, Jean A King2,4,5.   

Abstract

INTRODUCTION: Individuals with attention deficit/hyperactivity disorder (ADHD) are susceptible to earlier and more severe nicotine addiction. To shed light on the relationship between nicotine and ADHD, we examined nicotine's effects on functional brain networks in an animal model of ADHD.
METHODS: Awake magnetic resonance imaging was used to compare functional connectivity in adolescent (post-natal day 44 ± 2) males of the spontaneously hypertensive rat (SHR) strain and two control strains, Wistar-Kyoto and Sprague-Dawley (n = 16 each). We analyzed functional connectivity immediately before and after nicotine exposure (0.4 mg/kg base) in naïve animals, using a region-of-interest approach focussing on 16 regions previously implicated in reward and addiction.
RESULTS: Relative to the control groups, the SHR strain demonstrated increased functional connectivity between the ventral tegmental area (VTA) and retrosplenial cortex in response to nicotine, suggesting an aberrant response to nicotine. In contrast, increased VTA-substantia nigra connectivity in response to a saline injection in the SHR was absent following a nicotine injection, suggesting that nicotine normalized function in this circuit.
CONCLUSIONS: In the SHR, nicotine triggered an atypical response in one VTA circuit while normalizing activity in another. The VTA has been widely implicated in drug reward. Our data suggest that increased susceptibility to nicotine addiction in individuals with ADHD may involve altered responses to nicotine involving VTA circuits. IMPLICATIONS: Nicotine addiction is more common among individuals with ADHD. We found that two circuits involving the VTA responded differently to nicotine in animals that model ADHD in comparison to two control strains. In one circuit, nicotine normalized activity that was abnormal in the ADHD animals, while in the other circuit nicotine caused an atypical brain response in the ADHD animals. The VTA has been implicated in drug reward. Our results would be consistent with an interpretation that nicotine may normalize abnormal brain activity in ADHD, and that nicotine may be more rewarding for individuals with ADHD.
© The Author 2017. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28444321      PMCID: PMC5896460          DOI: 10.1093/ntr/ntx088

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  75 in total

1.  ADHD as a serious risk factor for early smoking and nicotine dependence in adulthood.

Authors:  Swantje Matthies; Sebastian Holzner; Bernd Feige; Corinna Scheel; Evgeniy Perlov; Dieter Ebert; Ludger Tebartz van Elst; Alexandra Philipsen
Journal:  J Atten Disord       Date:  2012-01-27       Impact factor: 3.256

2.  Nicotine-induced place conditioning and locomotor activity in an adolescent animal model of attention deficit/hyperactivity disorder (ADHD).

Authors:  Elizabeth Watterson; Carter W Daniels; Lucas R Watterson; Gabriel J Mazur; Ryan J Brackney; M Foster Olive; Federico Sanabria
Journal:  Behav Brain Res       Date:  2015-05-22       Impact factor: 3.332

3.  Differences in "bottom-up" and "top-down" neural activity in current and former cigarette smokers: Evidence for neural substrates which may promote nicotine abstinence through increased cognitive control.

Authors:  Liam Nestor; Ella McCabe; Jennifer Jones; Luke Clancy; Hugh Garavan
Journal:  Neuroimage       Date:  2011-04-01       Impact factor: 6.556

4.  Dopamine receptor blockade modulates the rewarding and aversive properties of nicotine via dissociable neuronal activity patterns in the nucleus accumbens.

Authors:  Ninglei Sun; Steven R Laviolette
Journal:  Neuropsychopharmacology       Date:  2014-06-04       Impact factor: 7.853

5.  Initial exposure to nicotine in college-age women smokers and never-smokers: a replication and extension.

Authors:  C S Pomerleau; O F Pomerleau; R J Namenek; J L Marks
Journal:  J Addict Dis       Date:  1999

6.  Volitional reduction of anterior cingulate cortex activity produces decreased cue craving in smoking cessation: a preliminary real-time fMRI study.

Authors:  Xingbao Li; Karen J Hartwell; Jeffery Borckardt; James J Prisciandaro; Michael E Saladin; Paul S Morgan; Kevin A Johnson; Todd Lematty; Kathleen T Brady; Mark S George
Journal:  Addict Biol       Date:  2012-03-28       Impact factor: 4.280

Review 7.  The genetic epidemiology of smoking.

Authors:  P F Sullivan; K S Kendler
Journal:  Nicotine Tob Res       Date:  1999       Impact factor: 4.244

8.  Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis.

Authors:  G J Kirouac; P K Ganguly
Journal:  Neuroscience       Date:  1993-01       Impact factor: 3.590

9.  Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD.

Authors:  Evangelia Stergiakouli; Marian Hamshere; Peter Holmans; Kate Langley; Irina Zaharieva; Ziarah Hawi; Lindsey Kent; Michael Gill; Nigel Williams; Michael J Owen; Michael O'Donovan; Anita Thapar
Journal:  Am J Psychiatry       Date:  2012-02       Impact factor: 18.112

10.  Adult attention-deficit/hyperactivity disorder and nicotine use: a qualitative study of patient perceptions.

Authors:  Michael Liebrenz; Anja Frei; Carl Erik Fisher; Alex Gamma; Anna Buadze; Dominique Eich
Journal:  BMC Psychiatry       Date:  2014-05-16       Impact factor: 3.630

View more
  1 in total

1.  Reducing the Prevalence of Smoking: Policy Measures and Focusing on Specific Populations.

Authors:  Adriaan W Bruijnzeel
Journal:  Nicotine Tob Res       Date:  2017-09-01       Impact factor: 4.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.